Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Alzheimer's Disease

• Publication date

  Unknown publication date

• Fields of study

  Biology, Sociology, Medicine, Environmental Science

• Identifiers
  DOI 10.3233/JAD-2008-15206PMID 18953109PMCID PMC2774209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer disease.

  2010cited by this paper
• Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease

  2009cited by this paper
• Abnormal Regional Cerebral Blood Flow in Cognitively Normal Elderly Subjects With Hypertension

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Vascular cognitive impairment: current concepts and clinical developments.

  2008cited by this paper
• Progression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2

  2008cited by this paper
• Oxidative stress and neurotoxicity.

  2008cited by this paper
• Risk factors of Alzheimer's disease among Iranian population.

  2008cited by this paper
• Angiotensin Converting Enzyme Inhibitors and Cognitive and Functional Decline in Patients with Alzheimer's Disease: An Observational Study

  2008cited by this paper
• Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2008cited by this paper
• Role of Advanced Glycation End Products in Hypertension and Atherosclerosis: Therapeutic Implications

  2007cited by this paper
• Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation

  2007cited by this paper
• Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2007cited by this paper
• Lipoic Acid and N-acetyl Cysteine Decrease Mitochondrial-Related Oxidative Stress in Alzheimer Disease Patient Fibroblasts

  2007cited by this paper
• Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide.

  2007cited by this paper
• Vascular oxidative stress in Alzheimer disease.

  2007cited by this paper
• Alzheimer disease, the two-hit hypothesis: an update.

  2007cited by this paper
• Autophagocytosis of Mitochondria Is Prominent in Alzheimer Disease

  2007cited by this paper
• Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron.

  2007cited by this paper
• The pathology of Alzheimer disease elicits an in vivo immunological response

  2007cited by this paper
• Shifting Paradigms in Dementia

  2007cited by this paper
• Blood–brain barrier impairment in Alzheimer disease

  2007cited by this paper
• S3–02–01: ADCS homocysteine trial

  2007cited by this paper
• O1–01–08: The Ginkgo in evaluation of memory (GEM) study design, recruitment, and incident dementia rates: A preliminary report

  2007cited by this paper
• Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide

  2007cited by this paper
• Signal Transduction Cascades Associated with Oxidative Stress in Alzheimer's Disease

  2007cited by this paper
• Overexpression of GRK2 in alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions

  2006cited by this paper
• Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.

  2006cited by this paper
• Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension

  2006cited by this paper
• Recommendations of the National Heart, Lung, and Blood Institute Working Group on Cerebrovascular Biology and Disease

  2006cited by this paper
• Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.

  2006cited by this paper
• Homocysteine and cognitive impairment; a case series in a General Practice setting

  2006cited by this paper
• Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

  2006cited by this paper
• Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey.

  2006cited by this paper
• The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

  2006cited by this paper
• NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease

  2006cited by this paper
• Endothelial aging.

  2005influential reference
• Elevated levels of homocysteine compromise blood-brain barrier integrity in mice.

  2005cited by this paper
• Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron*

  2005cited by this paper
• Small Vessel Disease and General Cognitive Function in Nondisabled Elderly: The LADIS Study

  2005cited by this paper
• Neurovascular mechanisms of Alzheimer's neurodegeneration.

  2005cited by this paper
• Developmental origins of aging in brain and blood vessels: an overview.

  2005cited by this paper
• Homocysteine and folate as risk factors for dementia and Alzheimer disease.

  2005cited by this paper
• Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease

  2005cited by this paper
• Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

  2004cited by this paper
• Recent trials of antioxidant therapy: what should we be telling our patients?

  2004cited by this paper
• Determinants of Platelet Activation in Human Essential Hypertension

  2004cited by this paper
• Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.

  2004cited by this paper
• Oxidative stress signalling in Alzheimer's disease.

  2004cited by this paper
• Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?

  2004cited by this paper
• Convergence of atherosclerosis and alzheimer's disease: Cholesterol, inflammation, and misfolded proteins.

  2004cited by this paper
• Reactive oxygen species in vascular biology: implications in hypertension

  2004cited by this paper
• Cortical Microinfarcts and Demyelination Significantly Affect Cognition in Brain Aging

  2004cited by this paper
• The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease

  2004cited by this paper
• Neurovascular regulation in the normal brain and in Alzheimer's disease

  2004cited by this paper
• Alzheimer's disease: the two-hit hypothesis

  2004cited by this paper
• The role of metabotropic glutamate receptors in Alzheimer's disease.

  2004cited by this paper
• Facts and recommendations about total homocysteine determinations: an expert opinion.

  2004cited by this paper
• Homocysteine, cerebrovascular disease and brain atrophy.

  2004cited by this paper
• A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease.

  2003cited by this paper
• Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension

  2003cited by this paper
• Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease

  2002cited by this paper
• Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals

  2002cited by this paper
• Oxidative Stress in Leukocytes Is a Possible Link Between Blood Pressure, Blood Glucose, and C-Reacting Protein

  2002cited by this paper
• Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

  2002cited by this paper
• Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

  2001cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• Homocysteine potentiates β‐amyloid neurotoxicity: role of oxidative stress

  2001cited by this paper
• Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress.

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Aging: Overview

  2001cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.

  2001cited by this paper
• Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

  2001cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine

  2001cited by this paper
• Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity

  2000cited by this paper
• Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats.

  2000cited by this paper
• Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome

  2000cited by this paper
• Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.

  2000cited by this paper
• Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.

  2000cited by this paper
• In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

  2000cited by this paper
• Redox metals and neurodegenerative disease.

  1999cited by this paper
• Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series

  1999cited by this paper
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999cited by this paper
• AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasison vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association.

  1999cited by this paper
• The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

  1999cited by this paper
• Nigral endothelial dysfunction, homocysteine, and Parkinson's disease.

  1999cited by this paper
• Diet and Oxidative Stress: A Novel Synthesis of Epidemiological Data on Alzheimer's Disease

  1999cited by this paper
• Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels.

  1999cited by this paper
• Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

  1999cited by this paper
• Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

  1998cited by this paper
• Relevance of vitamins, homocysteine and other metabolites in neuropsychiatric disorders

  1998cited by this paper
• Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid.

  1998cited by this paper
• Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease

  1998cited by this paper
• Abnormal localization of iron regulatory protein in Alzheimer's disease.

  1998cited by this paper
• Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.

  1998cited by this paper
• Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease

  1998cited by this paper
• Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

  1998cited by this paper
• Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine

  1998cited by this paper
• The Relation Between Antioxidants and Memory Performance in the Old and Very Old

  1997cited by this paper
• Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

  1997cited by this paper

• Measuring contractile forces in vascular smooth muscle cells.

  2025cites this paper
• Neuroprotective Effects of Shrimp Oil Against Oxidative Stress in Chronic Cerebral Hypoperfusion Rats

  2025cites this paper
• Association between oxidative balance score and gallstone in US adults: a cross-sectional study

  2025cites this paper
• Associations between Cognitive Impairment, Weight Status and Comorbid Conditions in Hospitalized Adults of 55 Years and Older in Guadeloupe

  2024cites this paper
• Associations between vascular health, brain stiffness and global cognitive function

  2024cites this paper
• The Role of Oxidative Stress and Natural Products in Maintaining Human Health

  2024cites this paper
• Improving Cognition Without Clearing Amyloid: Effects of Tau and Ultrasound Neuromodulation

  2024cites this paper
• Caffeic Acid Phenethyl Ester (CAPE): Biosynthesis, Derivatives and Formulations with Neuroprotective Activities

  2023cites this paper
• Natural products for the treatment of neurodegenerative diseases.

  2023cites this paper
• Progressive mechanical and structural changes in anterior cerebral arteries with Alzheimer’s disease

  2023cites this paper
• Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment

  2023cites this paper
• 11,12-Diacetyl-carnosol Protects SH-SY5Y Cells from Hydrogen Peroxide Damage through the Nrf2/HO-1 Pathway

  2022cites this paper
• Mapping blood traits to structural organization of the brain in rhesus monkeys.

  2022cites this paper
• Current Evidence on the Association of Micronutrient Malnutrition with Mild Cognitive Impairment, Frailty, and Cognitive Frailty among Older Adults: A Scoping Review

  2022cites this paper
• Luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-month-old diabetic animals.

  2021cites this paper
• An Infectious Origin of Alzheimer’s Disease: An End for This Devastating Disorder?

  2020cites this paper
• Amaryllidaceae alkaloids and neuronal cell protection

  2020cites this paper
• Discovery of dual cation-π inhibitors of acetylcholinesterase: design, synthesis and biological evaluation

  2020cites this paper
• A multibiomarker approach to evaluate the effect of polyaromatic hydrocarbon exposure on oxidative and genotoxic damage in tandoor workers

  2019cites this paper
• Neurochemical Aspects of Vascular Dementia

  2019cites this paper
• Acute and Chronic Exposure of Toluene Induces Genotoxicity in Different Regions of the Brain in Normal and Allergic Mouse Models

  2019cites this paper
• Evidence-based update on rosacea comorbidities and their common physiologic pathways.

  2018cites this paper
• Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review

  2018cites this paper
• Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer’s Disease

  2018cites this paper
• Ischemia/Reperfusion Damage in Diabetic Stroke

  2018cites this paper
• Flow-metabolism uncoupling in patients with asymptomatic unilateral carotid artery stenosis assessed by multi-modal magnetic resonance imaging

  2018cites this paper
• Sex‐related differences in oxidative stress and neurodegeneration

  2017cites this paper
• Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration

  2017cites this paper
• Perindopril Attenuates Lipopolysaccharide-Induced Amyloidogenesis and Memory Impairment by Suppression of Oxidative Stress and RAGE Activation.

  2016cites this paper
• New insights into coupling and uncoupling of cerebral blood flow and metabolism in the brain

  2016cites this paper
• G-protein coupled receptors as therapeutic targets for neurodegenerative and cerebrovascular diseases.

  2016cites this paper
• A combined supplementation of vitamin B12 and n-3 polyunsaturated fatty acids across two generations improves nerve growth factor and vascular endothelial growth factor levels in the rat hippocampus.

  2016cites this paper
• The impact of protein oxidation on sustained and white coat hypertension

  2016cites this paper
• Association of Inflammation and Possible Mild Cognitive Decline Measured by the Stroop Cognitive Function Test

  2016cites this paper
• Vaccination to Alzheimer Disease. Is it a Promising Tool or a Blind Way?

  2016cites this paper
• Involvement of the Nrf2/HO-1 signaling pathway in sulfuretin-induced protection against amyloid beta25-35 neurotoxicity.

  2015cites this paper
• Resveratrol protects against homocysteine‐induced cell damage via cell stress response in neuroblastoma cells

  2015influential citation
• Discovery of Characteristics of Patients with Increased Level of

  2015cites this paper
• Relationships between iron, oxidative stress, glycated proteins and the development of atherosclerosis in Type 2 diabetes

  2015cites this paper
• Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease.

  2015cites this paper
• Ischemia‐modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease

  2015cites this paper
• Brain Protection and Cognitive Function: Cocoa Flavonoids as Nutraceuticals.

  2015cites this paper
• The Impact of APOE Status on Relationship of Biomarkers of Vascular Risk and Systemic Inflammation to Neuropsychiatric Symptoms in Alzheimer's Disease

  2014cites this paper
• The associations between plasma homocysteine, vitamin B12, folate, the Apolipoprotein E genotype and Alzheimer's Disease

  2014cites this paper
• Reactive Oxygen species and cerebrovascular diseases

  2014cites this paper
• Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats

  2014cites this paper
• Oxidative Stress, Testosterone, and Cognition among Caucasian and Mexican-American Men with and without Alzheimer's Disease

  2014cites this paper
• Neuroprotective Properties of the Marine Carotenoid Astaxanthin and Omega-3 Fatty Acids, and Perspectives for the Natural Combination of Both in Krill Oil

  2014cites this paper
• Antioxidant activity of galantamine and some of its derivatives.

  2013cites this paper
• Attenuation of β-Amyloid-Induced Oxidative Cell Death by Sulforaphane via Activation of NF-E2-Related Factor 2

  2013cites this paper
• Triggers and Effectors of Oxidative Stress at Blood-Brain Barrier Level: Relevance for Brain Ageing and Neurodegeneration

  2013cites this paper
• Nrf2 in Host Defense: Over the Rainbow

  2013cites this paper
• Homocysteine, neural atrophy, and the effect of caloric restriction in rhesus monkeys.

  2012cites this paper
• Evaluation of genotoxicity and oxidative damage in painters exposed to low levels of toluene.

  2012cites this paper
• The Use of N-Ethylmaleimide for Mass Spectrometric Detection of Homocysteine Fractions in Blood Plasma

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• The effects of chronic copper exposure on the amyloid protein metabolisim associated genes' expression in chronic cerebral hypoperfused rats.

  2012cites this paper
• Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease.

  2012cites this paper
• Activity- and pharmacology-dependent modulation of adult neurogenesis in relation to Alzheimer’s disease

  2012cites this paper
• Plasma antioxidant capacity is reduced in Asperger syndrome.

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• valuation of genotoxicity and oxidative damage in painters exposed to low evels of toluene ngela

  2012cites this paper
• Role of nitric oxide and endocannabinoids in synaptic plasticity in the perirhinal cortex and in visual recognition memory

  2011cites this paper
• Changes in oxidative stress biomarker and gene expression levels in workers exposed to volatile organic compounds.

  2011cites this paper
• C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide.

  2011cites this paper
• Cerebral Amyloid Angiopathy, Blood-Brain Barrier Disruption and Amyloid Accumulation in SAMP8 Mice

  2011cites this paper
• The 894G > T (Glu298Asp) Variant in the Endothelial NOS Gene and MTHFR Polymorphisms Influence Homocysteine Levels in Patients with Cognitive Decline

  2011cites this paper
• Neurodegenerative processes in Alzheimer's disease: an overview of pathogenesis with strategic biomarker potential

  2011cites this paper
• A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.

  2011cites this paper
• Implicación de los metales y elementos traza en la enfermedad de alzheimer y su asociación con los agentes del estrés oxidativo sistémico

  2011cites this paper
• Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia

  2010cites this paper
• Neurochemical changes in a double transgenic mouse model of Alzheimer's disease fed a pro-oxidant diet.

  2010cites this paper
• Homocysteine enhances transmigration of rat monocytes through a brain capillary endothelial cell monolayer via ICAM-1.

  2010cites this paper
• Addictive Disorders in Nutritional Diseases ‐ From an Addictions Viewpoint

  2010cites this paper
• Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis

  2010cites this paper
• Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains.

  2010cites this paper
• The role of the blood-CNS barrier in CNS disorders and their treatment.

  2010cites this paper
• Acetyl-L-Carnitine Attenuates Okadaic Acid Induced Tau Hyperphosphorylation and Spatial Memory Impairment in Rats

  2010cites this paper
• Homocysteine, vitamin determinants and neurological diseases.

  2010cites this paper
• ral supplementation with Leu-Ile , a hydrophobic dipeptide , prevents the mpairment of memory induced by amyloid beta in mice via restraining the yperphosphorylation of extracellular signal-regulated kinase

  2010cites this paper
• Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.

  2010cites this paper
• Serum Homocysteine and Folate Levels are Associated With Late-life Dementia in a Korean Population

  2010cites this paper
• Neuropathology in the Adult Changes in Thought Study: A Review

  2009cites this paper
• Potential Mechanisms Involved in the Prevention of Neurodegenerative Diseases by Lithium

  2009cites this paper
• Does Alzheimer's disease begin in the brainstem?

  2009cites this paper
• All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease

  2009cites this paper
• Mitochondrial Drugs for Alzheimer Disease

  2009cites this paper
• Update on biological, social and economical aspect of Alzheimer's diasease and other dementia

  2009cites this paper
• Beneficial Effects of Cannabis Sativa Extract on Oxidative Stress

  year unknowncites this paper